Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A patient who is already metabolically healthy and wants to reduce visceral fat while preserving muscle may get far more value from a non-GLP-1 protocol
Blood glucose measurement: Blood samples were collected from the tail vein, and blood glucose levels were immediately analyzed using a glucometer (AccuChek, Germany) at each time point [1]
Common Side Effects Wegovy: nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, belching, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis
Some patients continue GLP-1 therapy long-term at a maintenance dose to support sustained weight loss
